Profitability
Weight: 25%
B-
65
- 5yr Avg ROIC 8.0%
- Operating Margin Trend +5.12 pp/yr
AZN
AstraZeneca PLC
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
C
52
- 5yr Avg ROE 10.9%
- 5yr Share-Count CAGR 2.3%
Growth Quality
Weight: 25%
A+
93
- 5yr Revenue CAGR 11.9%
- 5yr EPS CAGR 200.7%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
B
74
- 5yr FCF Margin 14.8%
- 5yr FCF/NI Conversion 7.82x
Balance Sheet
Weight: 10%
A-
83
- Net Debt / EBITDA 1.21x
- Interest Coverage (EBIT/Int) 8.32x
- Altman Z-Score 3.65
Stability
Weight: 5%
C+
60
- EPS Volatility (σ/μ) 0.65
- Piotroski F-Score 8
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 3 gurus held; 2 trimmed; 2 full exits.
- Holders
- 2 -1
- Avg Δ position
- -44.8%
- New buys
- 0
- Full exits
- 2
- Dalio sold -100%
- Greenblatt sold -100%
- Wood decreased -50%